comparemela.com

Latest Breaking News On - News ratings for acumen pharmaceuticals daily - Page 3 : comparemela.com

Baystate Wealth Management LLC Purchases Shares of 18,020 Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Baystate Wealth Management LLC Purchases Shares of 18,020 Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News-ratings-for-acumen-pharmaceuticals-daily
Pinnacle-associates-ltd
Acumen-pharmaceuticals-inc
Acumen-pharmaceuticals-trading-down
Tower-research-capital
Acumen-pharmaceuticals-profile
Baystate-wealth-management
Nasdaq
Prelude-capital-management
Quarter-for-acumen-pharmaceuticals
Deutsche-bank-aktiengesellschaft

Acumen Pharmaceuticals (NASDAQ:ABOS) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
Blackrock
United-kingdom-general
United-kingdom
America
Credit-suisse-group
Vanguard-group-inc
Acumen-pharmaceuticals-inc
Northern-trust-corp
Securities-exchange-commission
Millennium-management

Commodore Capital LP Has $1.62 Million Stock Position in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Commodore Capital LP reduced its stake in shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) by 19.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 400,000 shares of the company’s stock after selling 98,315 shares during the period. Commodore Capital LP owned approximately 0.98% of […]

United-states
America
Credit-suisse-group
Intrepid-financial-planning-group
Nasdaq
Cantor-fitzgerald
Acumen-pharmaceuticals-stock
Insider-transactions-at-acumen-pharmaceuticals
Acumen-pharmaceuticals-inc
Renaissance-technologies
Acumen-pharmaceuticals

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Director Jeffrey L. Ives Sells 41,949 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) Director Jeffrey L. Ives sold 41,949 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $6.49, for a total value of $272,249.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, […]

United-states
America
News-ratings-for-acumen-pharmaceuticals-daily
Renaissance-technologies
Credit-suisse-group
Dimensional-fund-advisors
Cantor-fitzgerald
Boothbay-fund-management
Nasdaq
Institutional-investors-weigh-in-on-acumen-pharmaceuticals
Prelude-capital-management

FY2023 EPS Estimates for Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Boosted by Cantor Fitzgerald

FY2023 EPS Estimates for Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Boosted by Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Chicago
Illinois
Montreal
Quebec
Canada
America
Hedge-funds-weigh-in-on-acumen-pharmaceuticals
Acumen-pharmaceuticals
Securities-exchange-commission

vimarsana © 2020. All Rights Reserved.